Cargando…

Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E–Deficient Mice

BACKGROUND: Although glycoursodeoxycholic acid (GUDCA) has been associated with the improvement of metabolic disorders, its effect on atherosclerosis remains elusive. This study aimed to investigate the role of GUDCA in the development of atherosclerosis and its potential mechanisms. METHODS AND RES...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Kan, Liu, Chenshu, Peng, Meixiu, Su, Qiao, Liu, Ruiming, Guo, Zeling, Chen, Sifan, Li, Zilun, Chang, Guangqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174342/ https://www.ncbi.nlm.nih.gov/pubmed/33787322 http://dx.doi.org/10.1161/JAHA.120.019820

Ejemplares similares

Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes
por: Chen, Bingting, et al.
Publicado: (2023)

Glycoursodeoxycholic acid ameliorates diet-induced metabolic disorders with inhibiting endoplasmic reticulum stress
por: Cheng, Lele, et al.
Publicado: (2021)

Resveratrol Promotes Angiogenesis in a FoxO1-Dependent Manner in Hind Limb Ischemia in Mice
por: Fan, Dongxiao, et al.
Publicado: (2021)

Enhanced autophagy alleviates injury during hindlimb ischemia/reperfusion in mice
por: Liu, Chenshu, et al.
Publicado: (2019)

Celastrol directly binds with VAMP7 and RAB7 to inhibit autophagy and induce apoptosis in preadipocytes
por: Liu, Chenshu, et al.
Publicado: (2023)

Progress in the Preclinical and Clinical Study of Resveratrol for Vascular Metabolic Disease
por: Fan, Dongxiao, et al.
Publicado: (2022)

Chronic apical periodontitis exacerbates atherosclerosis in apolipoprotein E‐deficient mice and leads to changes in the diversity of gut microbiota
por: Gan, Guowu, et al.
Publicado: (2021)

Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice
por: Zhao, Jingfei, et al.
Publicado: (2020)

Protocol for high-throughput screening of ACE2 enzymatic activators to treat COVID-19-induced metabolic complications
por: Chen, Pin, et al.
Publicado: (2022)

Major Lipids, Apolipoproteins, and Alterations of Gut Microbiota
por: Yun, Kyung Eun, et al.
Publicado: (2020)

Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry
por: Li, Zilun, et al.
Publicado: (2022)

PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice
por: Wu, Yao, et al.
Publicado: (2015)

Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites
por: Xie, Bin, et al.
Publicado: (2022)

The Role of Iron in Atherosclerosis in Apolipoprotein E Deficient Mice
por: Ma, Juan, et al.
Publicado: (2022)

Sicyos angulatus ameliorates atherosclerosis through downregulation of aortic inflammatory responses in apolipoprotein E-deficient mice
por: Kim, Yong-Hoon, et al.
Publicado: (2017)

Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs
por: Fang, Bin, et al.
Publicado: (2018)

Amelioration of atherosclerosis in apolipoprotein E-deficient mice by combined RNA interference of lipoprotein-associated phospholipase A(2) and YKL-40
por: Zhang, Hui, et al.
Publicado: (2018)

Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility
por: Li, Jing, et al.
Publicado: (2011)

TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice
por: Watt, Victoria, et al.
Publicado: (2011)

Betaine Supplementation Attenuates S-Adenosylhomocysteine Hydrolase-Deficiency-Accelerated Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Dai, Xin, et al.
Publicado: (2022)

Apolipoprotein E derived from CD11c(+) cells ameliorates atherosclerosis
por: Sauter, Manuela, et al.
Publicado: (2021)

Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Méndez-Lara, Karen Alejandra, et al.
Publicado: (2020)

Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation
por: Panyod, Suraphan, et al.
Publicado: (2022)

IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice
por: Mantani, Polyxeni T., et al.
Publicado: (2015)

Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E(−/−) Mice
por: Rinne, Petteri, et al.
Publicado: (2018)

Overexpression of CCN3 Inhibits Inflammation and Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Liu, Jun, et al.
Publicado: (2014)

Oridonin attenuates the progression of atherosclerosis by inhibiting NLRP3 and activating Nrf2 in apolipoprotein E-deficient mice
por: Wang, Lei, et al.
Publicado: (2023)

Deficiency of PSRC1 accelerates atherosclerosis by increasing TMAO production via manipulating gut microbiota and flavin monooxygenase 3
por: Luo, Tiantian, et al.
Publicado: (2022)

Mitochondria as novel mediators linking gut microbiota to atherosclerosis that is ameliorated by herbal medicine: A review
por: Li, Yujuan, et al.
Publicado: (2023)

Macrophage Paired Immunoglobulin-Like Receptor B Deficiency Promotes Peripheral Atherosclerosis in Apolipoprotein E–Deficient Mice
por: Su, Wenhua, et al.
Publicado: (2022)

Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis
por: Liu, Cong-Lin, et al.
Publicado: (2017)

Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E–deficient mice
por: Nigro, Patrizia, et al.
Publicado: (2011)

High phosphate diet reduces atherosclerosis formation in apolipoprotein E-deficient mice
por: Shiota, Asuka, et al.
Publicado: (2011)

CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice
por: Han, Juying, et al.
Publicado: (2018)

Traumatic Brain Injury Leads to Accelerated Atherosclerosis in Apolipoprotein E Deficient Mice
por: Wang, Jintao, et al.
Publicado: (2018)

PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction
por: Sun, Hua, et al.
Publicado: (2018)

Extract of Curcuma zedoaria R. prevents atherosclerosis in apolipoprotein E-deficient mice
por: Kim, Ki Mo, et al.
Publicado: (2021)

The Role of Gut Microbiota in Atherosclerosis and Hypertension
por: Ma, Junli, et al.
Publicado: (2018)

Prognostic value of clinical and morphologic findings in patients with type B aortic intramural hematoma
por: Li, Zilun, et al.
Publicado: (2020)

Adiponectin Receptor 2 Deficiency Results in Reduced Atherosclerosis in the Brachiocephalic Artery in Apolipoprotein E Deficient Mice
por: Lindgren, Anna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e8ae6v713hcn0t3plvk7o2n97i